S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Co. stock logo
CVS
CVS Health
$68.58
-0.7%
$75.53
$64.41
$83.25
$86.44B0.5210.91 million shs8.10 million shs
Haemonetics Co. stock logo
HAE
Haemonetics
$84.88
+0.8%
$78.72
$70.74
$95.26
$4.31B0.36443,038 shs359,409 shs
Signify Health, Inc. stock logo
SGFY
Signify Health
$30.49
$29.85
$10.70
$30.50
$7.21B0.372.48 million shsN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.25
+1.6%
$3.91
$1.79
$5.38
$53.27M0.91153,303 shs111,702 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Co. stock logo
CVS
CVS Health
-0.65%-3.56%-11.56%-7.17%-9.93%
Haemonetics Co. stock logo
HAE
Haemonetics
+0.80%-1.50%+11.98%+1.65%-0.14%
Signify Health, Inc. stock logo
SGFY
Signify Health
0.00%0.00%0.00%0.00%0.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+1.56%-2.99%-9.72%+19.93%-37.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CVS Health Co. stock logo
CVS
CVS Health
4.9968 of 5 stars
4.43.03.33.92.52.53.8
Haemonetics Co. stock logo
HAE
Haemonetics
3.985 of 5 stars
2.34.00.04.32.51.71.9
Signify Health, Inc. stock logo
SGFY
Signify Health
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.0616 of 5 stars
3.55.00.00.02.60.81.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Co. stock logo
CVS
CVS Health
2.80
Moderate Buy$89.4430.42% Upside
Haemonetics Co. stock logo
HAE
Haemonetics
2.50
Moderate Buy$104.6723.31% Upside
Signify Health, Inc. stock logo
SGFY
Signify Health
N/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$7.50130.77% Upside

Current Analyst Ratings

Latest SGFY, SRTS, HAE, and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
4/10/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
4/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$83.00 ➝ $76.00
4/4/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
3/15/2024
CVS Health Co. stock logo
CVS
CVS Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$93.00 ➝ $94.00
3/6/2024
CVS Health Co. stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$78.00
2/26/2024
CVS Health Co. stock logo
CVS
CVS Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
CVS Health Co. stock logo
CVS
CVS Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$88.00
2/13/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
2/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00
2/8/2024
CVS Health Co. stock logo
CVS
CVS Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$86.00 ➝ $84.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Co. stock logo
CVS
CVS Health
$357.78B0.24$12.10 per share5.67$59.55 per share1.15
Haemonetics Co. stock logo
HAE
Haemonetics
$1.17B3.69$4.98 per share17.06$16.22 per share5.23
Signify Health, Inc. stock logo
SGFY
Signify Health
$805.50M8.95$0.58 per share52.27$3.47 per share8.79
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$24.41M2.18$0.06 per share55.42$2.98 per share1.09

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Co. stock logo
CVS
CVS Health
$8.34B$6.4610.627.470.912.33%15.25%4.55%5/1/2024 (Confirmed)
Haemonetics Co. stock logo
HAE
Haemonetics
$115.40M$2.4634.5020.112.019.97%22.37%9.71%5/9/2024 (Confirmed)
Signify Health, Inc. stock logo
SGFY
Signify Health
-$576.80M-$3.29N/AN/AN/A-75.40%-10.24%-5.86%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$490K$0.03108.37N/A1.99%1.04%0.93%5/1/2024 (Estimated)

Latest SGFY, SRTS, HAE, and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$0.88N/A-$0.88N/AN/AN/A  
5/1/2024N/A
CVS Health Co. stock logo
CVS
CVS Health
$1.69N/A-$1.69N/AN/AN/A  
2/8/202412/31/2023
Haemonetics Co. stock logo
HAE
Haemonetics
$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      
2/8/2024Q4 2023
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.12$0.26+$0.14$0.26$12.10 million$12.57 million
2/7/202412/31/2023
CVS Health Co. stock logo
CVS
CVS Health
$2.01$2.12+$0.11$2.66$90.58 billion$93.81 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Co. stock logo
CVS
CVS Health
$2.663.88%+6.56%41.18%2 Years
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Signify Health, Inc. stock logo
SGFY
Signify Health
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A

Latest SGFY, SRTS, HAE, and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2024
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.39%4/19/20244/22/20245/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Co. stock logo
CVS
CVS Health
0.77
0.86
0.63
Haemonetics Co. stock logo
HAE
Haemonetics
0.91
2.92
1.76
Signify Health, Inc. stock logo
SGFY
Signify Health
0.41
1.62
1.62
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
11.76
8.23

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Co. stock logo
CVS
CVS Health
80.66%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
Signify Health, Inc. stock logo
SGFY
Signify Health
89.99%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
CVS Health Co. stock logo
CVS
CVS Health
0.24%
Haemonetics Co. stock logo
HAE
Haemonetics
1.79%
Signify Health, Inc. stock logo
SGFY
Signify Health
8.02%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
11.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.26 billionOptionable
Haemonetics Co. stock logo
HAE
Haemonetics
3,03450.79 million49.88 millionOptionable
Signify Health, Inc. stock logo
SGFY
Signify Health
2,200236.51 million217.54 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3516.39 million14.57 millionOptionable

SGFY, SRTS, HAE, and CVS Headlines

SourceHeadline
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest UpdateSensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
americanbankingnews.com - April 11 at 5:40 AM
Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Increase in Short InterestSensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Increase in Short Interest
marketbeat.com - March 28 at 11:58 AM
Sensus Healthcare Inc.Sensus Healthcare Inc.
wsj.com - March 23 at 2:11 AM
Sensus Healthcare to Participate in the 36th Annual Roth ConferenceSensus Healthcare to Participate in the 36th Annual Roth Conference
globenewswire.com - March 14 at 4:05 PM
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual MeetingSensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
globenewswire.com - March 13 at 8:00 AM
A Market With a HangoverA Market With a Hangover
realmoney.thestreet.com - March 11 at 1:19 PM
3 Stocks to Buy That Are Up 100% or More in 20243 Stocks to Buy That Are Up 100% or More in 2024
investorplace.com - February 25 at 2:02 PM
Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83
msn.com - February 24 at 4:42 AM
Sensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning CallsSensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning Calls
benzinga.com - February 23 at 5:28 PM
My Current Game Plan Includes Adding This Small-Cap Stock to My Watch ListMy Current Game Plan Includes Adding This Small-Cap Stock to My Watch List
realmoney.thestreet.com - February 21 at 8:19 PM
Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?
finance.yahoo.com - February 12 at 12:53 PM
Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesSensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
finance.yahoo.com - February 11 at 10:42 AM
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy RatingSensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
markets.businessinsider.com - February 10 at 3:48 PM
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call TranscriptSensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript
seekingalpha.com - February 9 at 7:12 PM
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call TranscriptSensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 9 at 2:11 PM
Q4 2023 Sensus Healthcare Inc Earnings CallQ4 2023 Sensus Healthcare Inc Earnings Call
finance.yahoo.com - February 9 at 9:10 AM
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial ResultsSensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
markets.businessinsider.com - February 8 at 7:56 PM
Sensus Healthcare announces U.S. patent for SRT-100 Vision SystemSensus Healthcare announces U.S. patent for SRT-100 Vision System
msn.com - February 8 at 9:55 AM
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) CapabilitiesSensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
finance.yahoo.com - February 8 at 9:55 AM
Earnings Preview For Sensus HealthcareEarnings Preview For Sensus Healthcare
benzinga.com - February 7 at 3:46 PM
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory RequirementsSensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
finance.yahoo.com - February 6 at 1:04 PM
Sensus Healthcare Announces Director Samuel O’Rear’s RetirementSensus Healthcare Announces Director Samuel O’Rear’s Retirement
msn.com - February 3 at 9:40 AM
Apple, Amazon and Meta Will Tell Us a Lot About This Markets HealthApple, Amazon and Meta Will Tell Us a Lot About This Market's Health
realmoney.thestreet.com - February 2 at 12:48 AM
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
finance.yahoo.com - February 1 at 9:38 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CVS Health logo

CVS Health

NYSE:CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Haemonetics logo

Haemonetics

NYSE:HAE
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Signify Health logo

Signify Health

NYSE:SGFY
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.
Sensus Healthcare logo

Sensus Healthcare

NASDAQ:SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.